Records containing: Leishmaniasis, Visceral
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-01A Multicenter Study on Leishmaniasis in Children: Clinical and Epidemiological Characteristics and Outcomes
-
CLINICAL_TRIALS study record update · 2025-04-24A Prospective Cohort Study on the Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis After Treatment for Primary Visceral Leishmaniasis in South Sudan
-
CLINICAL_TRIALS study record update · 2025-01-27Visceral Leishmaniasis in Emilia-Romagna
-
CLINICAL_TRIALS study record update · 2022-09-09Predicting Visceral Leishmaniasis in HIV Infected Patients
-
CLINICAL_TRIALS study record update · 2022-06-06Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-09-18A Phase II, Multi-centre, Open-label, Randomised Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral Sitamaquine Compared With Amphotericin B in the Treatment of Visceral Leishmaniasis Caused by L. Donovani in Endemic Areas.
-
CLINICAL_TRIALS study record update · 2011-06-02A Prospective, Multicentric, Randomized, Two Arm, Open Label Phase III Study To Assess Efficacy And Safety Of Infusion Of Amphomul® (Amphotericin B Emulsion) As Compared To Liposomal Amphotericin In Patients Of Visceral Leishmaniasis (Kala Azar)
-
CLINICAL_TRIALS study record update · 2010-05-26A Randomised, Open-label, Parallel-group, Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens (Co-administration), of AmBisome, Paromomycin and Miltefosine in Visceral Leishmaniasis (VL)
-
CLINICAL_TRIALS study record update · 2008-03-04Clinical Investigation of Infections Due to Leishmanial Parasites